Clinical Trial Update: AIMHI NT Relapse Prevention Trial [NA]

View source ↗

Summary

AIMHI NT Relapse Prevention Trial update (NCT00192582) sponsored by Menzies School of Health Research with listed conditions including schizophrenia and schizoa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizoaffective Disorder
• Schizophrenia
• Substance-induced Psychotic Disorder

Snippet

Sponsor: Menzies School of Health Research | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: UNKNOWN